Researchers of the RE-KINECT study (NCT03062033), aimed to understand the impact of tardive dyskinesia (TD) in patients treated with antipsychotics, and incorporated a unique element by focusing on the experiences of caregivers.
RE-KINECT Study Shows the Extensive Impact of Tardive Dyskinesia on Patients and Caregivers
Tori Gustafson2024-04-04T15:59:58+00:00April 4th, 2024|Tardive Dyskinesia|Comments Off on RE-KINECT Study Shows the Extensive Impact of Tardive Dyskinesia on Patients and Caregivers